Oncology drug developer OS Therapies refiles for $8M IPO (Pending:OSTX)
OS Therapies (OSTX) has refiled to raise $8M through a proposed initial public offering. The oncology drug developer said in...
OS Therapies (OSTX) has refiled to raise $8M through a proposed initial public offering. The oncology drug developer said in...
Immunocore (NASDAQ:IMCR) said that its cutaneous melanoma candidate brenetafusp was well tolerated and demonstrated durable clinical benefit as both monotherapy...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hypergrowth stocks have tremendous allure. Investing in just one company...
Shaun Maguire, a partner at the prominent venture capital firm Sequoia, announced he'll be cutting a $300,000 check to Donald...
Gold futures edged higher for the month of May despite turning lower on Friday, while the metal has dropped 4.5%...
Walmart made waves earlier this year when it announced it was upping pay for store managers, with some potentially able...
Nvidia, Microsoft and Apple all jockeyed this week for the title of world’s most valuable company as investors bet big...
I've worked at Costco for 18 years, so I have a few favorite high-quality items I like to get there.In...
Johnson & Johnson (NYSE:JNJ) said a new analysis of phase 3 data found that a combination of Rybrevant (amivantamab) and...
The S&P 500 and Nasdaq Composite may be smashing records, but commodities are doing some celebrating of their own. "People...